Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1. 10 minutes from the onset of the symptoms Figure 2.2 hour from the onset of the symptoms.

Similar presentations


Presentation on theme: "Figure 1. 10 minutes from the onset of the symptoms Figure 2.2 hour from the onset of the symptoms."— Presentation transcript:

1

2

3 Figure 1. 10 minutes from the onset of the symptoms Figure 2.2 hour from the onset of the symptoms

4

5

6 1. Popovsky MA, Abel MD, Moore SB: Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 2007; 128:185-189. 2. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985 Nov-Dec;25(6):573-7. 3. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. 2003 Feb 26;289(8):959-62. 4. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004 Jul;18(3):184-8. 5. Rana R, Fernández-Pérez ER, Khan SA, Rana S, Winters JL, Lesnick TG, Moore SB, Gajic O. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion. 2006 Sep;46(9):1478-83. 6. Barrett NA, Kam PC. Transfusion-related acute lung injury: a literature review. Anaesthesia. 2006 Aug;61(8):777-85. 7. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007 May 5;369(9572):1553-64. 8. Rubenfeld GD, Herridge MS. Epidemiology and outcomes of acute lung injury. Chest. 2007 Feb;131(2):554-62. 9. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med. 1951 Oct 15;51(20):2399-402. 10. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusion-related acute lung injury. Transfusion. 2001 Oct;41(10):1244-8. 11. Silliman CC. The two-event model of transfusion-related acute lung injury. Crit Care Med. 2006 May;34(5 Suppl):S124-31. 12. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res. 2004 Mar 19;94(5):664-70. 13. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, Ambruso DR. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997 Jul;37(7):719-26. 14. Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ. The pathology of transfusion-related acute lung injury. Am J Clin Pathol. 1999 Aug;112(2):216-21. 15. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL. Comparison of two fluid- management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564-75.


Download ppt "Figure 1. 10 minutes from the onset of the symptoms Figure 2.2 hour from the onset of the symptoms."

Similar presentations


Ads by Google